13F HOLDINGS REPORT
Euclidean Capital LLC
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001012975-23-000092
Total Value
$106.9M
Positions
11
Other Managers
0
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ISHARES TR | 46429B598 | 577,144 | $24.1M | 22.54% |
| 2 | 23ANDME HOLDING CO | 90138Q108 | 10,243,122 | $22.1M | 20.70% |
| 3 | PMV PHARMACEUTICALS INC | PMVP | 2,336,909 | $20.3M | 19.02% |
| 4 | ALECTOR INC | ALEC | 980,894 | $9.1M | 8.47% |
| 5 | RAPT THERAPEUTICS INC | 75382E109 | 432,900 | $8.6M | 8.02% |
| 6 | FOGHORN THERAPEUTICS INC | FHTX | 1,261,261 | $8.0M | 7.53% |
| 7 | ORIC PHARMACEUTICALS INC | ORIC | 747,550 | $4.4M | 4.12% |
| 8 | FIRST FINL BANCORP OH | 320209109 | 173,576 | $4.2M | 3.93% |
| 9 | NGM BIOPHARMACEUTICALS INC | 62921N105 | 746,674 | $3.7M | 3.51% |
| 10 | TENAYA THERAPEUTICS INC | TNYA | 915,705 | $1.8M | 1.72% |
| 11 | SURROZEN INC | SRZNW | 802,963 | $467,244 | 0.44% |